Cargando…

Can antipsychotic use protect from COVID-19?

Detalles Bibliográficos
Autores principales:	Dratcu, Luiz, Boland, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321781/ https://www.ncbi.nlm.nih.gov/pubmed/34352504 http://dx.doi.org/10.1016/j.schres.2021.07.035

Ejemplares similares

Antipsychotics and COVID-19: the debate goes on
por: Boland, Xavier, et al.
Publicado: (2021)

Clozapine in the Time of COVID-19
por: Boland, Xavier, et al.
Publicado: (2020)

Nicotine, cytokine storms and COVID-19
por: Boland, Xavier, et al.
Publicado: (2021)

Does Nicotine Prevent Cytokine Storms in COVID-19?
por: Dratcu, Luiz, et al.
Publicado: (2020)

An overall protective effect of antipsychotic drugs against COVID-19 seems implausible
por: Ruiz de Pellón-Santamaría, Ángel, et al.
Publicado: (2022)

COVID-19 and the emergence of inpatient tele-ward rounds
por: Boland, X., et al.
Publicado: (2022)

Anti-viral properties of antipsychotic medications in the time of COVID-19
por: Girgis, Ragy R., et al.
Publicado: (2021)

The role of antipsychotics against COVID-19: A topic for debate
por: Canal-Rivero, M., et al.
Publicado: (2021)

Acknowledging the Complexity of Antipsychotic Use in Long-Term Care During the COVID-19 Pandemic
por: Turcotte, Luke Andrew, et al.
Publicado: (2023)

Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022)

Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2023)

Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic
por: Ali, Mir M., et al.
Publicado: (2022)

Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
por: Alevizopoulos, Georgios, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
por: Ifteni, Petru, et al.
Publicado: (2020)

The ‘Holy Grail’ and ‘Poisoned Chalice’ Effects of Antipsychotics on Oxidative Stress in Schizophrenia: Can ‘Hormesis’ Explain this Paradox?
por: Venkatasubramanian, Ganesan
Publicado: (2012)

Repetitive and Stereotypic Vocalization in Dementia after Using Antipsychotics
por: Sung, Wonjae, et al.
Publicado: (2021)

Micronutrient supplementation before COVID-19 vaccination can protect against adverse effects
por: Dalan, Rinkoo, et al.
Publicado: (2022)

How 3D Printing Can Prevent Spread of COVID-19 Among Healthcare Professionals During Times of Critical Shortage of Protective Personal Equipment
por: Maracaja, Luiz, et al.
Publicado: (2020)

Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions
por: Gannon, Jessica M., et al.
Publicado: (2020)

Antipsychotics and OCD: Boon or Bane?
por: Naguy, Ahmed
Publicado: (2017)

Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021)

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

Online industry resources can help ensure continuity of care for patients on long-acting injectable antipsychotics while traveling or relocating
por: Brown, Geoffrey W, et al.
Publicado: (2023)

Can we use hydroxychloroquine to treat COVID-19 now?
por: Chen, Jun, et al.
Publicado: (2021)

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses
por: Prokopez, Cintia R., et al.
Publicado: (2021)

Clinical perspective on antipsychotic receptor binding affinities
por: Crapanzano, Calogero, et al.
Publicado: (2021)

Patient monitoring: the hidden costs of treatment with antipsychotics
por: Nederlof, Mariëtte, et al.
Publicado: (2016)

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
por: Periclou, Antonia, et al.
Publicado: (2019)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Protecting the elders from COVID- 19 impact-leveraging yoga
por: Venugopal, V., et al.
Publicado: (2020)

Parasites Protect from Severe COVID-19. Myth or Reality?
por: Makram, Abdelrahman M, et al.
Publicado: (2022)

Study of menstrual irregularities in patients receiving antipsychotic medications
por: Murke, Mukund P., et al.
Publicado: (2011)

Clozapine point of care testing in acute psychiatry: A precision approach to treatment resistant psychosis
por: Boland, X., et al.
Publicado: (2021)

Can hydroxychloroquine be used for COVID-19-induced arthritis? A debatable hypothesis
por: Swarnakar, Raktim, et al.
Publicado: (2022)

Comment: Personal protective equipment use in laparoscopy during COVID-19
por: Baksi, Aditya, et al.
Publicado: (2021)

COVID-19 and Digestive System Involvement: Can We Learn from the Past
por: Jadali, Zohreh
Publicado: (2021)

What lessons can African nations learn from the COVID-19 pandemic?
por: Akinola, Olanrewaju, et al.
Publicado: (2022)

Mask use by patients in the context of COVID‐19 can increase the risk of postinjection endophthalmitis
por: Blom, Kathrine, et al.
Publicado: (2021)

Radiological protection and biological COVID-19 protection in the nuclear medicine department
por: Ohnuki, Kazunobu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a65shk6nsm6u5kfdq3q7o5hqt4